Shares of Scholar Rock Holding Co. (NASDAQ:SRRK – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $28.25.
A number of brokerages have recently issued reports on SRRK. Wedbush raised their price objective on Scholar Rock from $27.00 to $37.00 and gave the company an “outperform” rating in a research note on Monday, October 7th. HC Wainwright raised their price objective on Scholar Rock from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Monday, October 7th. JPMorgan Chase & Co. reduced their price objective on Scholar Rock from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Thursday, October 3rd. Finally, BMO Capital Markets raised their price objective on Scholar Rock from $34.00 to $38.00 and gave the company an “outperform” rating in a research note on Friday.
Read Our Latest Analysis on SRRK
Insider Buying and Selling
Institutional Trading of Scholar Rock
Several institutional investors and hedge funds have recently bought and sold shares of SRRK. Clearbridge Investments LLC purchased a new stake in Scholar Rock in the second quarter worth about $6,223,000. Candriam S.C.A. purchased a new position in shares of Scholar Rock during the second quarter valued at approximately $6,201,000. Millennium Management LLC lifted its holdings in shares of Scholar Rock by 159.2% during the second quarter. Millennium Management LLC now owns 925,584 shares of the company’s stock valued at $7,710,000 after purchasing an additional 568,512 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of Scholar Rock by 1,051.3% during the second quarter. Marshall Wace LLP now owns 487,285 shares of the company’s stock valued at $4,059,000 after purchasing an additional 444,961 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Scholar Rock by 31.5% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,430,764 shares of the company’s stock valued at $26,898,000 after purchasing an additional 342,690 shares during the last quarter. 91.08% of the stock is currently owned by hedge funds and other institutional investors.
Scholar Rock Stock Up 1.4 %
SRRK opened at $26.51 on Monday. The stock has a market cap of $2.11 billion, a PE ratio of -12.68 and a beta of 0.82. The company has a quick ratio of 6.04, a current ratio of 6.04 and a debt-to-equity ratio of 0.36. Scholar Rock has a 52 week low of $6.48 and a 52 week high of $35.38. The business’s fifty day simple moving average is $10.71 and its 200 day simple moving average is $11.11.
Scholar Rock (NASDAQ:SRRK – Get Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.60) EPS for the quarter, beating analysts’ consensus estimates of ($0.61) by $0.01. During the same period in the prior year, the firm posted ($0.47) earnings per share. As a group, research analysts expect that Scholar Rock will post -2.38 earnings per share for the current fiscal year.
Scholar Rock Company Profile
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.
Read More
- Five stocks we like better than Scholar Rock
- 3 Tickers Leading a Meme Stock Revival
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Technology Stocks Explained: Here’s What to Know About Tech
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Consumer Staples Stocks, Explained
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter.